[출처/시간] United Press International - 3:38 PM ET, 05/21/2026 Eli Lilly said its weight loss drug, retatrutide, helped nearly half of participants in a phase 3 trial to lose more than 30% of their weight. Retatrutide affects three hormones-- GLP-1 and GIP, each of which are targeted by similar weight loss drugs, and glucagon, which none of them targets-- and could be best for people looking to lose larger amounts of weight, said the...
[출처/시간] United Press International - 3:38 PM ET, 05/21/2026
Eli Lilly said its weight loss drug, retatrutide, helped nearly half of participants in a phase 3 trial to lose more than 30% of their weight. Retatrutide affects three hormones-- GLP-1 and GIP, each of which are targeted by similar weight loss drugs, and glucagon, which none of them targets-- and could be best for people looking to lose larger amounts of weight, said the...
리포트 잘 봤습니다. 경쟁사 비교 차트가 한눈에 들어와서 좋네요. 다음 분기 가이던스가 어떻게 나올지 궁금합니다.
같은 섹터의 ETF 흐름도 함께 보면 더 좋을 것 같습니다.
의견 감사합니다. 곧 섹터 ETF 비교 차트를 별도 임베드로 추가할 예정입니다.